Biohaven Pharmaceuticals Inaugural Partner Of National Ataxia Foundation’s Drug Development Collaborative

NEW HAVEN, Conn., Nov. 11, 2020 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases including spinocerebellar ataxia, today announced its partnership with the National Ataxia Foundation (NAF) to help the nonprofit organization launch the NAF Drug Development Collaborative. As the first pharmaceutical industry member to commit support, Biohaven’s partnership will help NAF accelerate the development of new treatments for Ataxia.

Melissa Wolfe Beiner, M.D., Director of Research and Development and Clinical Lead for the Ataxia program at Biohaven, commented, “Biohaven is extremely pleased to be the first industry partner to join this important consortium. We are deeply committed to the Ataxia community, as demonstrated by our longstanding partnership with NAF and leading neurologists in the ataxia field from around the world. Together with NAF

Read More

Tya Winn takes helm at Philly Community Design Collaborative

The success that made her believe

Winn’s first triumph that made her think she could use design to change a community happened soon after she began working at Logan CDC in 2012.

Parklets, parks created in former parallel parking spaces, were popping up in University City. Logan CDC and the Mayor’s Office of Transportation and Utilities were behind the project. The parklets were all in traditional commercial corridors outside of restaurants, and they were functioning mainly as additional outdoor dining.

Winn reimagined the concept for the Logan Branch of The Free Library of Philadelphia. She wanted to create a space for people to read, work or just enjoy a public space. It was not a typical project at the time, but she convinced her boss at the CDC to let her do it.

“I was like, ‘Well, I’ll do the whole brand,’” she said. “I don’t need your grant writer.

Read More